MUMBAI, India, Oct. 24 -- Intellectual Property India has published a patent application (202441031282 A) filed by Apitoria Pharma Private Limited, Hyderabad, Telangana, on April 19, 2024, for 'novel crystalline form of gepotidacin mesylate and process for preparation.'
Inventor(s) include Mandad Pratap Reddy; Siva Rama Krishna Muppalla; Nasir Ali; and Praveen Kumar Neela.
The application for the patent was published on Oct. 24, under issue no. 43/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to novel polymorph of Gepotidacin Mesylate, designated as crystalline Gepotidacin Mesylate GEP-1 and process for the preparation thereof."
Disclaimer: Curated by HT Syndication....